ArticleJournal of fish diseases2026
Evaluation of Protective Efficacy of Formalin-Killed and Auxotrophic-Live Vibrio anguillarum Against Homologous and Heterologous Strains in Rainbow Trout (Oncorhynchus mykiss).
Article in Journal of fish diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Vibrio anguillarum infection poses a significant threat to freshwater and marine aquaculture. Although whole-cell killed and live attenuated vaccines are used to control vibriosis, their comparative efficacy against homologous and heterologous V. anguillarum strains remains limited. Here, we compared the protective efficacy and antibody responses of a formalin-killed V. anguillarum (FKC) and an alanine racemase gene knockout auxotrophic-live V. anguillarum (Δalr1Δalr2 V. anguillarum, LAV), both derived from the V. anguillarum JJ strain, in rainbow trout against homologous (JJ strain) and heterologous (V. anguillarum 90-11-287) strains. The LAV conferred superior protection compared to the FKC against both strains under high-dose challenge conditions. Despite this, ELISA antibody levels were comparable between vaccine groups and did not correlate with protective outcomes. No agglutination activity against the JJ strain was detected in vaccinated fish or rabbit antisera, suggesting limited assay sensitivity rather than absence of antibody binding. Analysis of the O-antigen biosynthesis-related genes revealed no genetic differences between strains; however, the JJ strain exhibited a shorter O-antigen, which may contribute to the reduced agglutination of the JJ strain. In conclusion, our results underscore the need for a comprehensive evaluation of vaccine performance, extending beyond antibody quantification, when developing effective vaccination strategies for aquaculture.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.